Loading
Fujian Cosunter Pharmaceutical Co., Ltd. Stock: price and insider trades · China
广生堂
No insider purchase over the last 90 days. The latest, by 黄伏虎, was filed 17 Mar 2022.
Fujian Cosunter Pharmaceutical Co., Ltd.: what insiders have been doing
Every trade that managers of Fujian Cosunter Pharmaceutical Co., Ltd. disclose to SSE / SZSE (CSRC) is tracked on this page. The company sits in the Health Care sector. Fujian Cosunter Pharmaceutical Co., Ltd. has had no insider filing for more than a year; the last one goes back to 17 March 2022.
Since 2022, the database holds 1 purchase and 2 sales by insiders of the company.
Elsewhere in the same sector, our signals recently picked up insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Insider Decl.
3
Thresholds
n/a
Buy Volume
€740
1 ops. · all time
Sell Volume
€6M
2 ops. · all time
Since the insiders bought
- -34.5%Entry CN¥50.50 · Close at T+365 CN¥33.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 21,202 of 26,280 companies
30.1
score / 100
Value31
Quality30
FCF yld-0.7%
Earn yld-1.7%
EV/EBITDA·
ROE-83%
Gross mgn62%
Net mgn-52%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CN¥79.98
Analyst consensus
Income statement
RevenueCN¥416.4M
Gross profitCN¥259.5M62% margin
EBITDA-CN¥103.3M-25% margin
Net income-CN¥217.8M-51.3% margin
Valuation
P/Book60.8x
Beta1.17
Balance sheet & cash
Market capCN¥13.4B
Total debtCN¥456M
Free Cash Flow-CN¥94.6M
Debt / Equity175%
Profitability & ownership
ROE-82.7%
ROA-6.6%
% insiders45.3%
% institutions3.0%
Last declaration on 17 March 2022
About Fujian Cosunter Pharmaceutical Co., Ltd.
广生堂 is a company in the health and pharmaceutical sector, listed on the XSHE market. It focuses on the development and production of medicines and health products.
